MedTrace Logo

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

NCT05880316 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-05-30

No results posted yet for this study

Summary

This study consists of 2 parts:

Part 1: a cross-sectional study, looking at the prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) among nurses in Hospital Canselor Tuanku Muhriz (HCTM).

Part 2: a randomized controlled trial of intermittent fasting with MAFLD subjects.

Conditions

  • Fatty Liver Disease

Interventions

BEHAVIORAL

Intermittent Fasting

3:4 regime

Sponsors & Collaborators

  • Universiti Kebangsaan Malaysia Medical Centre

    lead OTHER

Principal Investigators

  • Khairul Najmi M Nawawi · Gastroenterology Unit, Department of Medicine, Faculty of Medicine, UKM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-28
Primary Completion
2023-06-30
Completion
2023-08-31

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05880316 on ClinicalTrials.gov